Latest News about MRNA
Recent news which mentions MRNA
EXCLUSIVE: Robert F. Kennedy Jr. Takes Aim At Dr. Fauci In New Book On Pandemic-Era Policies
December 18, 2021
From Benzinga
3 Stocks to Buy If They Take a Dip
December 18, 2021
From Motley Fool
3 Investors Reflect on the Positive Outcomes of the Pandemic Era
December 17, 2021
From Motley Fool
3 Stocks Trading at a Discount Right Now: These Investors Are Still Skeptical About Buying
December 17, 2021
From Motley Fool
Reddit asks, ‘What’s surprised you the most about the pandemic?’ Here’s the most popular responses
December 17, 2021
From MarketWatch
This New Study Could Give Moderna a Big Advantage in 2022
December 17, 2021
From Motley Fool
Unvaccinated Americans facing ‘winter of severe illness and death,’ Biden warns, as omicron starts to spread across the U.S.
December 17, 2021
From MarketWatch
Investors Dump Tech Stocks in Favor of Value Stocks
December 17, 2021
From Benzinga
CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
December 17, 2021
From Benzinga
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
Why Moderna and Pfizer Beat the Market Today
December 16, 2021
From Motley Fool
Why Novavax, BioNTech, and Moderna Stocks Are Jumping This Week
December 16, 2021
From Motley Fool
While Novavax Stock Remains Cursed, It Might Be Time to Buy
December 16, 2021
From InvestorPlace
After a dazzling 2021 performance, here’s what contrarian investors are predicting for 2022, says Citi
December 16, 2021
From MarketWatch
Drug makers move forward with new COVID-19 booster candidates amid omicron’s spread and mass booster campaigns
December 15, 2021
From MarketWatch
8 S&P 500 Stocks Up More Than 100% In 2021
December 15, 2021
From Benzinga
From Benzinga
From Benzinga
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Moderna’s Long-Term Benefit Is Cursed by Short-Term Thinking
December 15, 2021
Tickers
MRNA
From InvestorPlace
From MarketWatch
Backlash Emerges To Elon Musk's Time Person Of The Year Cover
December 14, 2021
From Benzinga
Pfizer’s COVID-19 antiviral proves almost 90% effective in latest trial data, as U.S. passes 50 million confirmed cases of the illness
December 14, 2021
From MarketWatch
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
From Benzinga
Moderna, Australia Collaborate To Bring mRNA Manufacturing To Australia
December 14, 2021
Tickers
MRNA
From Benzinga
UK Reports First Omicron Death, PM Johnson Encourages Boosters
December 13, 2021
From Benzinga
Why BioNTech, Moderna, and Novavax Stocks Are Jumping Today
December 13, 2021
From Motley Fool
Better Buy: Ocugen vs. Novavax
December 13, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.